BIO
Bio-Rad Laboratories, Inc.
297.09
80 x undefined
400 x undefined
bid
ask
+
3.48
1.19%
240 @ 04:00 PM
297.09 +0.00 (0.00%)
| Ytd | -1.95% | |
| 1y | 19.80% |
293.06
day range
299.52
236.73
52 week range
343.12
| Open | 293.11 | Prev Close | 293.61 | Low | 293.06 | High | 299.52 | Mkt Cap | 7.95B |
| Vol | 167.38K | Avg Vol | 382.42K | EPS | 6.00 | P/E | 49.52 | Forward P/E | 30.59 |
| Beta | 1.08 | Short Ratio | 3.09 | Inst. Own | 94.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 283.19 | 200-d Avg | 293.84 | 1yr Est | 297.00 |
| Income Statement | |||
| Total Revenue | 592.10M | ||
| Revenues (USD) | 592.10M | ||
| Cost of Revenue | 282.70M | ||
| Gross Profit | 309.40M | ||
| Operating Expenses | 275.30M | ||
| Research and Development Expense | 62.90M | ||
| Selling, General and Administrative Expense | 212.40M | ||
| Operating Income | 34.10M | ||
| Interest Expense | 12.30M | ||
| Income Tax Expense | -162.70M | ||
| Net Income | -527.10M | ||
| Net Income Common Stock | -527.10M | ||
| Net Income Common Stock (USD) | -527.10M | ||
| Consolidated Income | -527.10M | ||
| Earnings per Basic Share | -19.55 | ||
| Earnings per Basic Share (USD) | -19.55 | ||
| Earnings per Diluted Share | -19.55 | ||
| Earning Before Interest & Taxes (EBIT) | -677.50M | ||
| Earning Before Interest & Taxes (USD) | -677.50M | ||
| Weighted Average Shares | 26.96M | ||
| Weighted Average Shares Diluted | 26.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 507.20M | ||
| Cash and Equivalents (USD) | 507.20M | ||
| Investments | 6.37B | ||
| Investments Current | 1.06B | ||
| Investments Non-Current | 5.31B | ||
| Trade and Non-Trade Receivables | 426.20M | ||
| Current Assets | 2.94B | ||
| Property, Plant & Equipment Net | 689.40M | ||
| Total Assets | 9.79B | ||
| Debt Current | 436.70M | ||
| Total Debt | 1.38B | ||
| Current Liabilities | 917.00M | ||
| Debt Non-Current | 941.50M | ||
| Total Liabilities | 2.94B | ||
| Accumulated Retained Earnings (Deficit) | 7.65B | ||
| Accumulated Other Comprehensive Income | -235.40M | ||
| Shareholders Equity | 6.85B | ||
| Shareholders Equity (USD) | 6.85B | ||
| Assets Non-Current | 6.85B | ||
| Total Debt (USD) | 1.38B | ||
| Goodwill and Intangible Assets | 743.90M | ||
| Inventory | 770.50M | ||
| Liabilities Non-Current | 2.02B | ||
| Trade and Non-Trade Payables | 133.10M | ||
| Tax Liabilities | 926.70M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -44.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -23.20M | ||
| Capital Expenditure | -29.90M | ||
| Issuance (Purchase) of Equity Shares | -43.90M | ||
| Issuance (Repayment) of Debt Securities | -100.00K | ||
| Net Cash Flow from Investing | -93.20M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -63.30M | ||
| Net Cash Flow from Operations | 108.10M | ||
| Effect of Exchange Rate Changes on Cash | 5.90M | ||